Valuation: Amgen Inc.

Market Cap 195B 170B 157B 145B 273B 18,713B 279B 1,879B 736B 9,144B 731B 714B 31,559B P/E 2026 *
23.6x
P/E 2027 * 21.7x
Enterprise Value 236B 207B 191B 177B 332B 22,747B 339B 2,284B 895B 11,116B 888B 868B 38,363B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 5.97x
Free-Float
99.78%
Yield 2026 *
2.8%
Yield 2027 * 2.96%
1 day-1.44%
1 week-3.49%
Current month-1.90%
1 month+0.01%
3 months+1.23%
6 months+7.99%
Current year+8.54%
1 week 354.71
Extreme 354.71
368.75
1 month 334.05
Extreme 334.0501
375.25
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 224.34
Extreme 224.335
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-3.49%+19.60%+56.20% 195B
-2.48%-6.72%+44.19%+156.43% 1,054B
-1.52%-5.01%+61.87%+58.79% 621B
-1.30%-3.88%+27.81%+79.97% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.04%-4.63%+16.01%+68.47% 163B
-0.94%+0.75%-4.34%-33.23% 140B
Average -0.80%-1.21%+20.71%+43.12% 369.57B
Weighted average by Cap. -0.38%-1.50%+31.75%+72.88%

Financials

2026 *2027 *
Net sales 37.74B 33.05B 30.55B 28.18B 53.05B 3,631B 54.13B 365B 143B 1,774B 142B 139B 6,123B 38.65B 33.85B 31.28B 28.86B 54.33B 3,718B 55.44B 373B 146B 1,817B 145B 142B 6,271B
Net income 8.22B 7.2B 6.65B 6.14B 11.55B 791B 11.79B 79.39B 31.1B 386B 30.87B 30.19B 1,333B 8.85B 7.75B 7.16B 6.61B 12.44B 851B 12.69B 85.5B 33.49B 416B 33.24B 32.51B 1,436B
Net Debt 41.94B 36.72B 33.95B 31.32B 58.94B 4,034B 60.15B 405B 159B 1,971B 158B 154B 6,804B 36.29B 31.78B 29.37B 27.1B 51B 3,491B 52.05B 351B 137B 1,706B 136B 133B 5,887B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-14 $355.25 -1.44% 1,862,864
26-07-13 $360.45 -0.81% 2,064,665
26-07-10 $363.39 -0.06% 1,632,715
26-07-09 $363.62 -1.19% 1,728,241
26-07-08 $367.99 -0.03% 1,758,925
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
355.25USD
Average target price
356.62USD
Spread / Average Target
+0.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock